Editas Medicine (EDIT) Net Margin Growth (1y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -3,082.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1,120.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -653.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 7,849.00 |
| 10 | Editas Medicine | 338.62 Mn | 338.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 10.15 Mn |
| Jun 30, 2025 | 1.17 Mn |
| Mar 31, 2025 | 383,431.00 |
| Dec 31, 2024 | -11,691.00 |
| Sep 30, 2024 | -10.10 Mn |
| Jun 30, 2024 | -1.18 Mn |
| Mar 31, 2024 | -497,698.00 |
| Dec 31, 2023 | 89,782.00 |
| Sep 30, 2023 | 13.18 Mn |
| Jun 30, 2023 | -55,144.00 |
| Mar 31, 2023 | 26,090.00 |
| Dec 31, 2022 | -59,692.00 |
| Sep 30, 2022 | -13.21 Mn |
| Jun 30, 2022 | 1.37 Mn |
| Mar 31, 2022 | 13,060.00 |
| Dec 31, 2021 | 21,502.00 |
| Sep 30, 2021 | -64,341.00 |
| Jun 30, 2021 | -1.44 Mn |
| Mar 31, 2021 | -21,403.00 |
| Dec 31, 2020 | -23,985.00 |
| Sep 30, 2020 | 86,850.00 |
| Jun 30, 2020 | 123,075.00 |
| Mar 31, 2020 | 75,451.00 |
| Dec 31, 2019 | 10,197.00 |
| Sep 30, 2019 | -75,110.00 |
| Jun 30, 2019 | -92,477.00 |
| Mar 31, 2019 | -62,582.00 |
| Dec 31, 2018 | 57,744.00 |
| Sep 30, 2018 | 31,846.00 |
| Jun 30, 2018 | 32,843.00 |
| Mar 31, 2018 | 377,182.00 |
| Dec 31, 2017 | 339,797.00 |
| Sep 30, 2017 | 176,162.00 |
| Jun 30, 2017 | -29,165.00 |
| Mar 31, 2017 | -234,949.00 |
| Dec 31, 2016 | -277,728.00 |
| Sep 30, 2016 | -106,428.00 |
| Jun 30, 2016 | 2.80 Mn |